Abstract
In diseases such as cancer and more generally chronic conditions randomized clinical trials often use time to occurrence of a given event as the main response criterion. Survival time, i. e., time to death, is the most widely used of such criteria. Other examples include disease-free interval, duration of a remission period, or time to occurrence of a thrombosis. Such criteria are termed “censored” because at the time the analysis is performed the event has not been observed for each patient in the trial.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Armitage P (1975) Sequential medical trials, 2nd edn. Blackwell, Oxford
Bénichou J, Chastang Cl (1986 a) A simulation study of three sequential methods for the comparison of two treatment groups, when the response criterion is censored. Stat Med 5: 375–385
Bénichou J, Chastang Cl (1986 b) Mise en oeuvre de méthodes séquentielles dans les essais thérapeutiques randomisés dont le critère de jugement est censuré. Rev Epidemiol Sante Publique 34(3): 196–208
Binet JL, Auquier A, Dighiero G, Chastang Cl, Piguet H, Cosguen J, Vaugier G, Potron G, Colona P, Oberling F, Thomas M, Tchernia G, Jacquillat Cl, Boivin P, Lesty C, Duault MT, Monconduit M, Belabbes S, Grémy F (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate analysis. Cancer 48: 198–206
Decroix G, Chastang Cl, Fichet D, Asselain B, Lebeau B, Morice V, Lepage T, Babo P, Fa-bre C, Rebishung JL, Accard JL, Hinault G, Sauvaget J, Rochemaure J, Soubrane Cl, Ja-gueux M, Toty L, Herzog P, Daumet P, Grosset J, Grémy F (1984) Adjuvant immunother-apy with nonviable Mycobacterium smegmatis in resected primary lung carcinoma. Cancer 53(4): 906–912
DeMets DL, Ware JM (1980) Group sequential methods for clinical trials with a one-sided hypothesis. Biometrika 67: 651–660
Freedman LS (1982) Tables of the number of patients required in clinical trials using the log-rank test. Stat Med 1: 121–129
French Cooperative Group on Chronic Lymphocytic Leukemia (1986) Effectiveness of CHOP regimen in advanced untreated chronic lymphocytic leukemia. Lancet 1: 1346–1349
Gail MH, DeMets DL, Slud EV (1982) Simulation studies on increments of two-sample log-rank score test for survival data, with application to group sequential boundaries. In: Johnson R, Crowley J (eds) Survival analysis monograph series 2, IMS lecture notes. Hayward, CA
George SL, Desu MM (1974) Planning the size and duration of a clinical trial studying the time to some critical event. J Chronic Dis 27: 15–29
Jones DR, Whitehead J (1979) Sequential forms of the log-rank and modified Wilcoxon test for censored data. Biometrika 66: 105–113
Jones DR, Newman CE, Whitehead J (1982) The design of a sequential clinical trial for the comparison of two lung cancer treatments. Stat Med 1: 73–82
Lan KKG, Simon R, Halperin N (1982) Stochastically curtailed tests in long-term clinical trials. Commun Stat Sequential Anal 1: 207–219
O’Brien PC, Fleming TR (1979) A multiple testing procedure for clinical trials. Biometrics 35: 549–556
Pocock SJ (1977) Group sequential methods in the design and analysis of clinical trials. Biometrika 64: 191–199
Pocock SJ (1978) The size of cancer clinical trials and stopping rules. Br J Cancer 38: 757–766
Pocock SJ (1983) Clinical trials. A practical approach. Wiley, Chichester
Rubinstein LV, Gail MH, Santner TJ (1981) Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observations. J Chronic Dis 34: 469–479
Wang SK, Tsiatis AA (1987) Approximately optimal one-parameter boundaries for group sequential trials. Biometrics 43:193–199
Whitehead J (1983) The design and analysis of sequential clinical trials. Horwood, Chichester
Whitehead J, Stratton I (1983) Group sequential clinical trials with triangular continuation regions. Biometrics 39: 227–236
Whitehead J, Jones DR, Ellis SH (1983) The analysis of a sequential clinical trial for the comparison of two lung cancer treatments. Stat Med 2: 183–190
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Bénichou, J., Chastang, C. (1988). Statistical Properties and Use of Sequential Methods in Randomized Clinical Trials when the Response Criterion Is Censored. In: Scheurlen, H., Kay, R., Baum, M. (eds) Cancer Clinical Trials. Recent Results in Cancer Research, vol 111. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83419-6_25
Download citation
DOI: https://doi.org/10.1007/978-3-642-83419-6_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83421-9
Online ISBN: 978-3-642-83419-6
eBook Packages: Springer Book Archive